Reaction
Engraft Failure reporting signals
As of the last recalculation, Engraft Failure appears in 282 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is ANTI-THYMOCYTE GLOBULIN (RABBIT) (PRR 377.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anti-Thymocyte Globulin (Rabbit) | 36 | 377.4 | 379.1 |
| Busulfan | 55 | 320.3 | 321.4 |
| Melphalan Hydrochloride | 58 | 214.7 | 215.2 |
| Fludarabine Phosphate | 76 | 194.9 | 195.3 |
| Micafungin Sodium | 20 | 187.3 | 187.8 |
| Melphalan | 40 | 151.1 | 151.3 |
| Mesna Injection | 13 | 121.7 | 121.9 |
| Mesna | 13 | 119.4 | 119.6 |
| Filgrastim | 44 | 102.1 | 102.2 |
| Thiotepa | 11 | 88.4 | 88.5 |
| Ganciclovir | 10 | 74.7 | 74.8 |
| Hydrocortisone Sodium Succinate | 9 | 73.0 | 73.0 |
| Itraconazole | 11 | 72.3 | 72.4 |
| Ganciclovir Sodium | 10 | 72.3 | 72.3 |
| Granisetron Hydrochloride | 9 | 65.7 | 65.7 |
| Cefepime Hydrochloride | 13 | 62.4 | 62.4 |
| Cyclophosphamide Injection, Solution | 88 | 52.9 | 52.9 |
| Cyclophosphamide | 88 | 52.9 | 52.9 |
| Cyclophosphamide For Injection | 88 | 52.9 | 52.9 |
| Cytarabine | 30 | 41.1 | 41.1 |